Table 3.
Parameter | Cohort C (n=290)
|
||
---|---|---|---|
Hazard ratio | 95% CI | P-value | |
uPA mRNA (Q4 versus Q1–3) | 2.86 | 1.36–6.01 | 0.006* |
PAI-1 mRNA (>median) | 1.85 | 1.01–3.42 | 0.048* |
Tumor size (<2 cm) | 0.43 | 0.23–0.78 | 0.006* |
Grade (G3) | 1.10 | 1.04–1.18 | 0.003* |
Nodal status (positive) | 1.16 | 0.61–2.23 | 0.652 |
ER status (positive) | 0.55 | 0.29–1.06 | 0.072 |
Note:
Statistically significant.
Abbreviations: CI, confidence interval; ER, estrogen receptor; uPA, urokinase plasminogen activator; PAI-1, plasminogen activator inhibitor.